Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Sight Sciences Inc (SGHT)

Sight Sciences Inc (SGHT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 430,907
  • Shares Outstanding, K 52,872
  • Annual Sales, $ 79,870 K
  • Annual Income, $ -51,510 K
  • EBIT $ -45 M
  • EBITDA $ -44 M
  • 60-Month Beta 2.41
  • Price/Sales 5.55
  • Price/Cash Flow N/A
  • Price/Book 6.77

Options Overview Details

View History
  • Implied Volatility 338.17% (+28.41%)
  • Historical Volatility 81.88%
  • IV Percentile 70%
  • IV Rank 25.38%
  • IV High 1,087.56% on 03/06/25
  • IV Low 83.27% on 04/01/25
  • Expected Move (DTE 1) 1.45 (17.73%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 4
  • Volume Avg (30-Day) 13
  • Put/Call OI Ratio 0.01
  • Today's Open Interest 910
  • Open Int (30-Day) 924
  • Expected Range 6.71 to 9.60

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate -0.17
  • Number of Estimates 3
  • High Estimate -0.10
  • Low Estimate -0.24
  • Prior Year -0.23
  • Growth Rate Est. (year over year) +26.09%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.56 +24.24%
on 11/21/25
8.80 -7.39%
on 11/28/25
+1.12 (+15.93%)
since 11/17/25
3-Month
3.19 +155.49%
on 10/10/25
8.80 -7.39%
on 11/28/25
+4.73 (+138.30%)
since 09/17/25
52-Week
2.03 +301.48%
on 04/08/25
8.80 -7.39%
on 11/28/25
+4.53 (+125.14%)
since 12/17/24

Most Recent Stories

More News
New Peer-Reviewed Publications Highlight Effectiveness of OMNI® Surgical System with TruSync™ Technology in Reducing IOP and Medication Usage in Cataract Combination Procedures, Standalone Procedures, and in African Americans

MENLO PARK, Calif., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare company focused on developing and commercializing innovative, interventional...

SGHT : 8.15 (-2.86%)
Sight Sciences Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Revenue Guidance

MENLO PARK, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc . (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,...

SGHT : 8.15 (-2.86%)
Sight Sciences Appoints Ali Bauerlein as Chief Operating Officer and Jim Rodberg as Chief Financial Officer

MENLO PARK, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare technology company focused on developing and commercializing innovative,...

SGHT : 8.15 (-2.86%)
Sight Sciences to Present at Two Upcoming Investor Conferences

MENLO PARK, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- Sight Sciences , Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,...

SGHT : 8.15 (-2.86%)
Sight Sciences to Report Third Quarter 2025 Financial Results on November 6, 2025

MENLO PARK, Calif., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Sight Sciences , Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,...

SGHT : 8.15 (-2.86%)
Sight Sciences Announces Fee Schedule Establishment from Novitas Solutions and First Coast Service Options for the TearCare® Interventional Dry Eye Procedure

MENLO PARK, Calif., Oct. 17, 2025 (GLOBE NEWSWIRE) -- Sight Sciences , Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,...

SGHT : 8.15 (-2.86%)
Sight Sciences (SGHT) Gets a Buy from UBS

In a report released yesterday, Danielle Antalffy from UBS reiterated a Buy rating on Sight Sciences, with a price target of $5.00. The company’s shares opened today at $3.35.Elevate Your Investing Strategy:...

SGHT : 8.15 (-2.86%)
Sight Sciences Announces Publication of a Systematic Literature Review and Meta-Analysis Showing OMNI® Surgical System Achieves Clinically Significant, Long-Term Reductions in IOP and Medication Use

MENLO PARK, Calif., Sept. 17, 2025 (GLOBE NEWSWIRE) -- Sight Sciences , Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,...

SGHT : 8.15 (-2.86%)
Sight Sciences Announces the OMNI® Surgical System to be Included in UnitedHealthcare’s® Expanded Coverage of Glaucoma Surgical Treatments

MENLO PARK, Calif., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Sight Sciences , Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing innovative,...

SGHT : 8.15 (-2.86%)
Sight Sciences Announces Recognition of the TearCare® System in TFOS DEWS III Global Dry Eye Guidelines Published in AJO

MENLO PARK, Calif., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Sight Sciences , Inc. (Nasdaq: SGHT) (Sight Sciences or the Company) an eyecare technology company focused on developing and commercializing innovative,...

SGHT : 8.15 (-2.86%)

Business Summary

Sight Sciences Inc. is a medical device company. It focused on the development and commercialization of proprietary devises which target the underlying causes of prevalent eye diseases. Sight Sciences Inc. is based in MENLO PARK, Calif.

See More

Key Turning Points

3rd Resistance Point 9.21
2nd Resistance Point 8.97
1st Resistance Point 8.56
Last Price 8.15
1st Support Level 7.91
2nd Support Level 7.67
3rd Support Level 7.26

See More

52-Week High 8.80
Last Price 8.15
Fibonacci 61.8% 6.21
Fibonacci 50% 5.41
Fibonacci 38.2% 4.62
52-Week Low 2.03

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar